Two Sigma Investments
SKYE icon

Two Sigma Investments’s Skye Bioscience SKYE Stock Holding History

Two Sigma Investments’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8K Sell
25,684
-26,022
-50% -$21.2K ﹤0.01% 4517
2025
Q4 		$38.8K Sell
51,706
-40,612
-44% -$59.3K ﹤0.01% 3961
2025
Q3 		$363K Buy
92,318
+29,163
+46% +$110K ﹤0.01% 3131
2025
Q2 		$264K Buy
63,155
+46,548
+280% +$96.3K ﹤0.01% 2835
2025
Q1 		$26.4K Buy
+16,607
New +$45.3K ﹤0.01% 3087

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Two Sigma Investments's SKYE Position: Q1 2026 in Review

Two Sigma Investments reduced its Skye Bioscience (SKYE) stake by 50% in Q1 2026, selling an estimated $21.2K and leaving 25,684 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4517.

Two Sigma Investments first reported a position in SKYE in Q1 2025 and has held it in 5 quarters since. The position peaked at $363K in Q3 2025. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

  • Two Sigma Investments held 25,684 shares of Skye Bioscience worth $15.8K as of Q1 2026.
  • Two Sigma Investments sold 26,022 Skye Bioscience shares in Q1 2026, an estimated $21.2K.
  • Skye Bioscience made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4517 holding.
  • Two Sigma Investments first reported a position in Skye Bioscience in Q1 2025 and has held it in 5 quarters since.
  • Two Sigma Investments's Skye Bioscience position peaked at $363K in Q3 2025.
  • 39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.